Trials / Terminated
TerminatedNCT00403234
Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study to Evaluate the Analgesic Efficacy of BTDS on Postoperative Pain During Rehabilitation Following Total Knee Arthroplasty
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Purdue Pharma LP · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objectives in this study are to evaluate: (1) efficacy of buprenorphine transdermal system (BTDS, Butrans™) on postoperative pain following total knee replacement surgery; (2) the impact of BTDS on functional rehabilitative measures after total knee replacement surgery; and 3) the safety of BTDS after total knee replacement surgery. The double-blind treatment period is for 28 days during which time supplemental analgesic medication will be provided to all subjects in addition to study drug. Purdue Pharma L.P. terminated the trial early due to administrative reasons not related to efficacy or safety. The focus of this study became safety evaluations.
Detailed description
Buprenorphine is a synthetic opioid analgesic with over 25 years of international clinical experience indicating it to be safe and effective in a variety of therapeutic situations for the relief of moderate to severe pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine transdermal patch | Buprenorphine transdermal patch 10 mcg/h applied for 7-day wear. |
| DRUG | Buprenorphine transdermal patch | Buprenorphine transdermal patch 20 mcg/h applied for 7-day wear. |
| DRUG | Buprenorphine transdermal patch | Buprenorphine transdermal patches 10 mcg/h and 20 mcg/h (total of 30 mcg/h) applied for 7-day wear. |
| DRUG | Placebo BTDS | Placebo to match BTDS transdermal 10 and 20 patches applied for 7-day wear. |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-04-01
- Completion
- 2007-08-01
- First posted
- 2006-11-23
- Last updated
- 2012-09-03
- Results posted
- 2010-09-21
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00403234. Inclusion in this directory is not an endorsement.